Characterisation of islet antibody-negative type 1 diabetes mellitus in Indian children.

IF 3.2 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Jayakrishnan C Menon, Pratibha Singh, Archana Archana, Uma Kanga, Preeti Singh, Medha Mittal, Atul Garg, Anju Seth, Vijayalakshmi Bhatia, Preeti Dabadghao, Siddhnath Sudhanshu, Ruchira Vishwakarma, Shivendra Verma, S K Singh, Eesh Bhatia
{"title":"Characterisation of islet antibody-negative type 1 diabetes mellitus in Indian children.","authors":"Jayakrishnan C Menon, Pratibha Singh, Archana Archana, Uma Kanga, Preeti Singh, Medha Mittal, Atul Garg, Anju Seth, Vijayalakshmi Bhatia, Preeti Dabadghao, Siddhnath Sudhanshu, Ruchira Vishwakarma, Shivendra Verma, S K Singh, Eesh Bhatia","doi":"10.1111/dme.15477","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Islet antibody-negative type 1 diabetes mellitus (T1DM) has not been well characterised. We determined the frequency of antibody-negative T1DM and compared it with antibody-positive T1DM in a cohort of north Indian children.</p><p><strong>Methods: </strong>In a multi-centre, prospective, observational study, 176 Indian children (age 1-18 years) were assessed within 2 weeks of diagnosis of T1DM. Antibodies against GAD65 (GADA), islet antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A), were estimated using validated ELISA. HLA-DRB1, DQA1 and DQB1 alleles were studied by Luminex-based typing. Monogenic diabetes was determined by targeted next-generation sequencing using the Illumina platform.</p><p><strong>Results: </strong>After excluding 12 children with monogenic diabetes, GADA, IA-2A and ZnT8A were present in 124 (76%), 60 (37%) and 62 (38%) o children, respectively, while 24 (15%) were negative for all antibodies. A single antibody (most frequently GADA) was present in 68 (41%) of children, while all three antibodies were found in 34 (21%). Islet antibody-negative T1DM (n = 24, 15%) did not differ from antibody-positive children in their clinical features, HbA1c or plasma C-peptide, both at onset or after 1 year follow-up (available in 62 children). The frequency of other organ-specific antibodies or high-risk HLA-DR and DQ alleles were also similar. Children with a single islet antibody did not differ from those with multiple antibodies.</p><p><strong>Conclusions: </strong>The frequency of various islet-antibodies, in isolation and combination, differed considerably from studies among children of European descent with T1DM. Children with T1DM who were islet antibody-negative were indistinguishable from those who were antibody-positive.</p>","PeriodicalId":11251,"journal":{"name":"Diabetic Medicine","volume":" ","pages":"e15477"},"PeriodicalIF":3.2000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetic Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dme.15477","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Islet antibody-negative type 1 diabetes mellitus (T1DM) has not been well characterised. We determined the frequency of antibody-negative T1DM and compared it with antibody-positive T1DM in a cohort of north Indian children.

Methods: In a multi-centre, prospective, observational study, 176 Indian children (age 1-18 years) were assessed within 2 weeks of diagnosis of T1DM. Antibodies against GAD65 (GADA), islet antigen-2 (IA-2A) and zinc transporter 8 (ZnT8A), were estimated using validated ELISA. HLA-DRB1, DQA1 and DQB1 alleles were studied by Luminex-based typing. Monogenic diabetes was determined by targeted next-generation sequencing using the Illumina platform.

Results: After excluding 12 children with monogenic diabetes, GADA, IA-2A and ZnT8A were present in 124 (76%), 60 (37%) and 62 (38%) o children, respectively, while 24 (15%) were negative for all antibodies. A single antibody (most frequently GADA) was present in 68 (41%) of children, while all three antibodies were found in 34 (21%). Islet antibody-negative T1DM (n = 24, 15%) did not differ from antibody-positive children in their clinical features, HbA1c or plasma C-peptide, both at onset or after 1 year follow-up (available in 62 children). The frequency of other organ-specific antibodies or high-risk HLA-DR and DQ alleles were also similar. Children with a single islet antibody did not differ from those with multiple antibodies.

Conclusions: The frequency of various islet-antibodies, in isolation and combination, differed considerably from studies among children of European descent with T1DM. Children with T1DM who were islet antibody-negative were indistinguishable from those who were antibody-positive.

印度儿童胰岛抗体阴性 1 型糖尿病的特征。
目的:胰岛抗体阴性的1型糖尿病(T1DM)尚未得到很好的描述。我们确定了抗体阴性 T1DM 的发病率,并将其与抗体阳性 T1DM 的发病率进行了比较:在一项多中心、前瞻性、观察性研究中,176 名印度儿童(1-18 岁)在确诊 T1DM 两周内接受了评估。使用有效的酶联免疫吸附法估测了 GAD65(GADA)、胰岛抗原-2(IA-2A)和锌转运体 8(ZnT8A)的抗体。通过基于 Luminex 的分型对 HLA-DRB1、DQA1 和 DQB1 等位基因进行了研究。通过使用 Illumina 平台进行有针对性的新一代测序确定了单基因糖尿病:排除12名单基因糖尿病患儿后,124名(76%)、60名(37%)和62名(38%)患儿体内分别存在GADA、IA-2A和ZnT8A,24名(15%)患儿体内所有抗体均为阴性。68(41%)名儿童体内存在一种抗体(最常见的是 GADA),34(21%)名儿童体内存在三种抗体。胰岛抗体阴性的T1DM患儿(24人,15%)与抗体阳性患儿在临床特征、HbA1c或血浆C肽方面没有差异,无论是在发病时还是随访1年后(62名患儿)。其他器官特异性抗体或高危 HLA-DR 和 DQ 等位基因的频率也相似。只有一种胰岛抗体的儿童与有多种抗体的儿童没有区别:各种胰岛抗体的单独或联合出现频率与欧洲血统 T1DM 患儿的研究结果差别很大。胰岛抗体阴性的T1DM患儿与抗体阳性的患儿没有区别。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetic Medicine
Diabetic Medicine 医学-内分泌学与代谢
CiteScore
7.20
自引率
5.70%
发文量
229
审稿时长
3-6 weeks
期刊介绍: Diabetic Medicine, the official journal of Diabetes UK, is published monthly simultaneously, in print and online editions. The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans. Categories of publication include research articles, reviews, editorials, commentaries, and correspondence. All material is peer-reviewed. We aim to disseminate knowledge about diabetes research with the goal of improving the management of people with diabetes. The journal therefore seeks to provide a forum for the exchange of ideas between clinicians and researchers worldwide. Topics covered are of importance to all healthcare professionals working with people with diabetes, whether in primary care or specialist services. Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to know diabetes better and fight diabetes more effectively on behalf of all people affected by and at risk of diabetes as well as their families and carers.”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信